A new analysis of five clinical trials suggests that using lung ultrasound to guide treatment in heart failure patients may reduce the risk of hospitalization or death. The review combined data from 1095 people with heart failure. It compared standard care with care guided by lung ultrasound, a quick, bedside scan that checks for fluid in the lungs.
The results showed that patients whose treatment was guided by ultrasound had a 28% lower risk of being hospitalized for heart failure or dying from any cause. They also had a 35% lower risk of heart failure hospitalization and a 62% lower risk of urgent visits for heart failure. The safety profile was similar between the two groups, with no significant differences in side effects like low blood pressure, kidney problems, or electrolyte imbalances.
This is a meta-analysis, which means it combines results from several smaller studies. While the findings are promising, the individual studies were small and had different designs. More research is needed to confirm these results and to see if they apply to all heart failure patients.
For now, this review suggests that lung ultrasound could be a useful tool to help doctors tailor treatment for heart failure. If you have heart failure, talk to your doctor about the best monitoring and treatment plan for you.